biotransformation - pt 1 Flashcards
what is biotransformation
enzymatic changes made to a substance
what is a phase I reaction
oxidation - CYP450
what is a phase II reaction
- glucuronidation/glucosidation
- acetylation
most metabolic products are:
pharmacologically LESS active
what is a prodrug
the metabolite is MORE active than the substance administered
what are examples of prodrugs
- cefpodoxime proxetil
- erythromycin-ethylsuccinate
- codeine
what are the two types of oxidative reactions
- oxygen is incorporated into the drug molecule (addition of ‘-OH’)
- oxidation causes the loss of part of the drug molecule
what is cytochrome P450
- mixed function oxidases or monooxygenases
- present mostly in the microsomes, some also in mitochondria
what does drug oxidation require
CYP450 (enzyme); NADPH-CYP450 reductase (enzyme); NADPH (cofactor); and O2 (cofactor)
what are the 4 steps of oxidation via CYP450
- oxidized CYP450 combines with a drug substrate to form complex
- NADPH donates 2 electrons to NADPH-CYP450 reductase - 1E reduces Fe3+ in the cytochrome P450-drug complex to Fe2+. the Fe2+-CYP450-drug complex binds O2
- 2E from NADPH-CYP450 reducase reduces O2 and forms an “activated oxygen”- Fe2+-CYP450-substrate complex
- complex transfers “activated” oxygen to the drug substrate to form the oxidized product, the second activated O atom is used to form H2O
chemically diverse small molecules are converted to:
more polar compounds = more water soluble aka hydrophilic
what are 3 functions of CYP450
- activation/inactivation of drugs
- chemical carcinogenesis
- participation in physiological pathways
most of the drug metabolizing enzymes are in ____ families
CYP 1,2, & 3
in humans, ____ and ____ are the most likely to be responsible for drug biotransformation; their presence in the GI tract is responsible for poor bioavailability of many drugs administered orally
CYP3A4/5; CYP2D6
glucuronidation is done by
UDP-glucuronosyltransferase
acetylation is done by
acetyltransferase
in glucuronidation, lipophilic substrate binds to the ____ active site via Phe90
UDP-glucuronosyltransderase (enzyme)
the “activated” substrate performs nucleophilic attack on C1 of ____
UDP-glucuronic acid (cofactor)
what enzyme is found in many tissues, including liver
acetylation
N-acetyl transderase (NAT)
N-acetyl transderase (NAT) requires the cofactor ____ to supple the acetyl group
acetyl Co-enzyme A
CYP2C9 and 2C19 are involved in what (NSAIDS)
the hydroxylation at different positions
what carboxylated NSAIDS
cytosolic ALDH1 and ALDH2
what is pharmacogenomics
the study of genes that influence ADME of drugs
what are the phase I CYP450 differences
- greyhounds have lower CYP2B11 activoty - results in lower Vd for lipophilic drugs b/c limited fat
- cats dont have CYP2B6 - hepatic necrosis after receiving diazepam
- horses have low CYP2D - monesin toxicity
- mini/micro pigs have increased CYP in general and need higher doses
CYP2D6 polymorphism affects drug metabolism
poor, intermediate, efficient, or ultrarapid
what are the phase II differences
- cats: lack glucoronidation - slow aspirin clearance + acetominophen toxicity
- Dogs: N-acetyltransferase deficiency & thiopurine methyltransferase
- pigs: lack sulfate conjugation
- avian and reptiles: unique AA conjugation
phase I metabolism in neonates
- reduced
- increases progressively during first 6 mo
- exceeds adult rates by first few years for some drugs
- slows during adolescence
- adult rates may be achieved by some drugs 2-4 wks postnatally
phase II metabolism neonates
- varies considerably
- decreased conjugation for bilirubin and acetaminophen
- normal morphine conjugation
effect of age - elderly
- decreases with age
- phase I - prolonged
- phase II - no change
first pass metabolism: reduced 1% per year
effect of pregnancy - hepatic clearance
affected by progesterone
effect of pregnancy - cholestatic effects of estrogen
decreases bile secretion
effect of diet
- grapefruit juice
- st john’s wort, other herbal products
what are the 3 major categories of CYP inducers
- phenobarbital
- polycylic aromatic hydrocarbons
- glucocorticoids
what is an inhibitor od CYP450s
azole family antifungals